Catalyst Wire Dossier Catalyst Wire Dossier

Afimetoran

Afimetoran
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Afimetoran, covering 2024-08-07 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) [Phase 2]

See pricing